Managing Device Upgrades Without Triggering Major Supplements: Strategy for 2026

Managing Device Upgrades Without Triggering Major Supplements: Strategy for 2024 Managing Device Upgrades Without Triggering Major Supplements: Strategy for 2024 In the rapidly evolving landscape of medical devices and combination products, understanding how to manage device upgrades is essential for ensuring compliance with regulatory requirements. This guide outlines a systematic approach to navigating post-approval regulatory consulting, particularly focusing on how to execute device upgrades while minimizing the risk of triggering major supplements. Step 1: Understand the Regulatory Framework Before embarking on a device upgrade, it is critical to comprehend the regulatory landscape defined by the FDA and other relevant bodies,…

Continue Reading... Managing Device Upgrades Without Triggering Major Supplements: Strategy for 2026

Global Renewals and Technical File Updates: Coordinating US and EU Timelines in 2026

Global Renewals and Technical File Updates: Coordinating US and EU Timelines in 2023 Global Renewals and Technical File Updates: Coordinating US and EU Timelines in 2023 In the intricate landscape of regulatory affairs, managing the lifecycle of combination products poses unique challenges, particularly regarding global renewals and technical file updates. This guide provides a step-by-step framework for regulatory professionals involved in FDA combination product consulting, ensuring compliance with both U.S. and EU regulations. This comprehensive overview focuses on aligning timelines for global renewals and technical file updates in 2023, outlining practical actions and documentation expectations throughout each phase. Step 1:…

Continue Reading... Global Renewals and Technical File Updates: Coordinating US and EU Timelines in 2026

Discontinuation and Device Replacement Strategy: Regulatory and Commercial Risk Controls in 2026

Discontinuation and Device Replacement Strategy: Regulatory and Commercial Risk Controls in 2023 Discontinuation and Device Replacement Strategy: Regulatory and Commercial Risk Controls in 2023 With the dynamic landscape of pharmaceutical and medical device industries, having a robust Discontinuation and Device Replacement Strategy is crucial. This strategy not only assures compliance with regulatory requirements but also safeguards commercial interests. This detailed step-by-step tutorial outlines effective methodologies to manage discontinuation and device replacements while adhering to pertinent regulations established by the FDA and other authorities. Key areas covered include regulatory frameworks, documentation, risk assessment, and monitoring post-market commitments. Step 1: Understanding Regulatory…

Continue Reading... Discontinuation and Device Replacement Strategy: Regulatory and Commercial Risk Controls in 2026